Accelerated aging in women
A new study has found that for healthy women carrying a well-known genetic risk factor for Alzheimer's disease, estrogen therapy that could be beneficial. Women with the risk factor exhibited signs of accelerated biological aging. However, among at-risk women who used estrogen, the acceleration was absent. In this podcast, Natalie Rasgon, MD, PhD, director of the Stanford Center for Neuroscience in Women's Health and a senior author of the study, discusses the findings and how the research may help determine the types of women who might benefit from hormone therapy.